Effects of substituents on the NMR features of basic bicyclic ring systems of fluoroquinolone antibiotics and the relationships between NMR chemical shifts, molecular descriptors and drug-likeness parameters
By: Milena Takač
Open Access
|Dec 2010References
- P. C. Appelbaum and P. A. Hunter, The fluoroquinolone antibacterials: past, present and future perspectives,(2000) 5-15; DOI: 10.1016/S0924-8579(00)00192-8.
- D. C. Hooper,(Eds. D. C. Hooper and E. Rubinstein), AMS Press, Washington 2003, pp. 3-40.
- S. Emami, A. Shafiee and A. Foroumadi, Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria,(2006) 375-386; DOI: 10.2174/138955706776361493.
- K. E. Brighty and T. D. Gootz, The chemistry and biological profile of trovafloxacin,(1997) 1-14; DOI: 10.1093/jac/39.suppl_2.1.
- M. P. Montanari, M. Prenna, M. Mingoia, S. Ripa and P. E. Varaldo, In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones,(1998) 85-93; DOI: 10.1159/000007097.
- J. Vincent, R. Teng, D. K. Dalvie and H. L. Friedman, Pharmacokinetics and metabolism of single oral doses of trovafloxacin,(1998) 8S-13S; DOI: 10.1016/S0002-9610(98)00213-X.
- D. Scuster, C. Laggner and T. Lagner,(Ed. R. Vaz and T. Klabunde), Wiley WCH Verlag GmbH & Co. KGaA, Weinheim 2008, pp. 3-22.
- M. J. Liguori, M. G. Anderson, S. Bukofzer, J. McKim, J. F. Pregenzer, J. Retief, B. B. Spear and J. F. Waring, Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin,(2005) 177-186; DOI: 10.1124/jpet.105.096347.
- Q. Sun, R. Zhu, F. W. Foss, Jr. and T. L. Macdonald, Mechanisms of trovafloxacin hepatotoxicity: studies of a model cyclopropylamine-containing system,(2007) 6682-6686; DOI: 10.1016/j.bmd.2007.10.070.
- Q. Sun, R. Zhu, F. W. Foss, Jr. and T. L. Macdonald, In vitro metabolism of a model cyclopropylamine to reactive intermediate: Insights into trovafloxacin-induced hepatotoxicity,(2008) 711-719; DOI: 10.1021/tx7003085.
- J. M. Domagala, Structure-activity and structure-side-effect relationships for the quinolone antibacterials,(1994) 685-706; DOI: 10.1093/jac/33.4.685.
- G. S. Tillotson, Quinolones: structure-activity relationships and future predictions,(1996) 320-324; DOI: 10.1099/00222615-44-5-320.
- L. Mandell and G. Tillotson, Fluoroquinolone safety: An overview evaluating safety and antimicrobial activity profiles based on molecular structure categorized adverse effects,(2002) 54-61.
- Y. Tsuzuki, K. Tomita, K. Shibamori, Y. Sato, S. Kashimoto and K. Chiba, Synthesis and structure-activity relationships of novel 7-substituted 1,4 dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as anti-tumor agents, part-2,(2004) 2097-2109; DOI: 10.1021/jm0304966.
- M. Paul, A. Gafter-Gvili, A. Fraser and L. Leibovici, The anti-cancer effects of quinolone antibiotics?,(2007) 825-831; DOI: 10.1007/s10096-007-0375-4.
- T. Norris and G. Ferry,, U.S. Pat. 6,114,531, 5 Sep. 2005.
- E. Rubinstein, History of quinolones and their side-effects,(2001) 3-8; 44-48; DOI: 10.1159/000057838.
- P. J. Shaw, A. M. Fullerton, M. A. Scott, P. E. Ganey and R. A. Roth, The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability,(2009) 293-300; DOI: 10.1016/j.taap.2009.01.018.
- C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings,(1997) 4-25; DOI: 10.1016/S0169-409X(00)00129-0.
- D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward and K. D. Kopple, Molecular properties that influence the oral bioavailability of drug candidates,(2002) 2615-2623; DOI: 10.1021/jm020017n.
- P. Ertl, B. Rohde and P. Selzer, Fast calculation of molecular polar surface area as a sum of fragent-based contributions and its application to the prediction of drug transport properties,(2000) 3714-3717; DOI: 10.1021/jm000942e.
- H. O. Kalinowski, S. Berger and S. Braun,, Georg Thieme Verlag, Stuttgart 1984.
- R. M. Silverstein, C. C. Bassler and T. C. Morrill,, 5th ed., Wiley, New York 1991.
- G. Fardella, P. Barbetti, I. Chiappini and G. Grandolini, Quantitative analysis of fluoroquinolones byH andF-NMR spectroscopy,(1995) 123-127; DOI: 10:1016/0378-5173(95)00038-K.
- A. Zieba, A. Mašlankiewicz and J. Sitkovski,H,C andN NMR spectra of ciprofloxacin,(2004) 903-904; DOI: 10.1002/mrc.1468.
Language: English, Croatian
Page range: 237 - 254
Published on: Dec 6, 2010
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2010 Milena Takač, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.